Zogenix Inc. buy melinda
Start price
22.06.17
/
50%
€13.44
Target price
29.09.17
€30.00
Performance (%)
79.10%
End price
29.09.17
€24.07
Summary
This prediction ended on 29.09.17 with a price of €24.07. With a performance of 79.10% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Zogenix Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by melinda for this prediction
In the thread Zogenix Inc. diskutieren
* Zogenix Inc. - 22. Juni erteilte die US FDA seine experimentelle Droge, die Ausweisung von Orphan - ZX008 Medikament für die Behandlung von Lennox-Gastaut - Syndrom
(Vom Mitglied beendet)